Aspen Pharmacare Holdings Ltd (APN):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C7718)
◆英語タイトル:Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7718
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:55
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Aspen Pharmacare Holdings Ltd (APN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company focuses on thrombosis, anesthetics and high potency and cytotoxics therapeutic categories. It also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturing capabilities cover a range of product-types including oral solid dose, semi-solids, liquids, steriles, biological, active pharmaceutical ingredients (APIs) and infant nutritionals. The company has presence in Sub-Saharan Africa, Latin America, South East Asia, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Ltd Key Recent Developments

May 07,2018: Aspen Opens R1 Billion High Containment Facility
Mar 22,2018: Aspen Presented With The Ubuntu Economic Diplomacy (Africa) Award
Mar 08,2018: Aspen delivers double digit revenue and earnings growth
Sep 14,2017: Aspen increases revenue by 16% to R41.2 billion
Jun 13,2017: Aspen: South African Competition Commission Announcement

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Aspen Pharmacare Holdings Ltd – Key Facts 6
Aspen Pharmacare Holdings Ltd – Key Employees 7
Aspen Pharmacare Holdings Ltd – Key Employee Biographies 8
Aspen Pharmacare Holdings Ltd – Major Products and Services 9
Aspen Pharmacare Holdings Ltd – History 10
Aspen Pharmacare Holdings Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 16
Section 2 – Company Analysis 17
Company Overview 17
Aspen Pharmacare Holdings Ltd – Business Description 18
Business Segment: Commercial Pharma 18
Overview 18
Performance 19
Business Segment: Manufacturing 19
Overview 19
Performance 19
Business Segment: Nutritionals 19
Overview 19
Performance 19
Geographical Segment: Asia Pacific 20
Performance 20
Geographical Segment: Developed Europe 20
Performance 20
Geographical Segment: Developing Europe and CIS 20
Performance 20
Geographical Segment: Latin America 20
Performance 20
Geographical Segment: MENA 20
Performance 20
Geographical Segment: Sub-Saharan Africa 20
Performance 20
Geographical Segment: USA & Canada 20
Performance 20
Aspen Pharmacare Holdings Ltd – Corporate Strategy 21
Aspen Pharmacare Holdings Ltd – SWOT Analysis 22
SWOT Analysis – Overview 22
Aspen Pharmacare Holdings Ltd – Strengths 22
Aspen Pharmacare Holdings Ltd – Weaknesses 23
Aspen Pharmacare Holdings Ltd – Opportunities 24
Aspen Pharmacare Holdings Ltd – Threats 25
Aspen Pharmacare Holdings Ltd – Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios – Capital Market Ratios 27
Financial Ratios – Annual Ratios 28
Performance Chart 31
Financial Performance 31
Financial Ratios – Interim Ratios 32
Financial Ratios – Ratio Charts 33
Section 4 – Company’s Lifesciences Financial Deals and Alliances 34
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Aspen Pharmacare Holdings Ltd, Recent Deals Summary 36
Section 5 – Company’s Recent Developments 37
May 07, 2018: Aspen Opens R1 Billion High Containment Facility 37
May 07, 2018: Aspen Opens R1 Billion High Containment Facility 38
Mar 22, 2018: Aspen Presented With The Ubuntu Economic Diplomacy (Africa) Award 39
Mar 22, 2018: Aspen Presented With The Ubuntu Economic Diplomacy (Africa) Award 40
Mar 08, 2018: Aspen delivers double digit revenue and earnings growth 41
Sep 14, 2017: Aspen increases revenue by 16% to R41.2 billion 44
Jun 13, 2017: Aspen: South African Competition Commission Announcement 47
May 29, 2017: Aspen concludes strategic M.O.U with the Russian Federation 48
May 29, 2017: Aspen Cleared of Alleged Anti-competitive Behavior by DA 49
May 15, 2017: Aspen: Opening of European Commission proceedings 50
Section 6 – Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Aspen Pharmacare Holdings Ltd, Key Facts 6
Aspen Pharmacare Holdings Ltd, Key Employees 7
Aspen Pharmacare Holdings Ltd, Key Employee Biographies 8
Aspen Pharmacare Holdings Ltd, Major Products and Services 9
Aspen Pharmacare Holdings Ltd, History 10
Aspen Pharmacare Holdings Ltd, Other Locations 13
Aspen Pharmacare Holdings Ltd, Subsidiaries 13
Aspen Pharmacare Holdings Ltd, Joint Venture 16
Aspen Pharmacare Holdings Ltd, Key Competitors 26
Aspen Pharmacare Holdings Ltd, Ratios based on current share price 27
Aspen Pharmacare Holdings Ltd, Annual Ratios 28
Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont...1) 29
Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont...2) 30
Aspen Pharmacare Holdings Ltd, Interim Ratios 32
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Aspen Pharmacare Holdings Ltd, Recent Deals Summary 36
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List of Figures
Aspen Pharmacare Holdings Ltd, Performance Chart (2014 - 2018) 31
Aspen Pharmacare Holdings Ltd, Ratio Charts 33
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Aspen Pharmacare Holdings Ltd (APN):企業の財務・戦略的SWOT分析(Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆